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Trisha L Dunning, Helen Leach, Melita Van De Vreede, Allison F Williams, John Buckley,
John Jackson, Anne Leversha, Roger L Nation, Catherine Rokahr, Mary O’Reilly,
Suzanne W Kirsa
ABSTRACT
Background: Medicine-related adverse events are prevalent,
costly and mostly preventable. The High Risk Medicines
Working Party (Victoria) developed and distributed three high-
risk medicines alerts – wrong route of administration of oral
medicines, subcutaneous insulin and unfractionated heparin –
and accompanying audit tools in 2008 and 2009.
Aims: To determine the impact of the three high-risk medicines
alerts on Victorian health services; to assess the clinical relevance
and utility of the audit tools; to identify barriers to
implementing recommendations; and to obtain feedback and
suggestions for future alert topics.
Method: A cross-sectional survey was undertaken from 6 to
31 July 2009 using an online questionnaire. The questionnaire
was distributed to 90 metropolitan, regional and rural public
health services in Victoria and approximately 200 members of
the Quality Use of Medicines Network (Victoria).
Results: Most of the 90 respondents were pharmacists (53%)
and nurses (31%). 53 (59%) respondents reported making
changes as a result of receiving the high-risk medicines alerts –
21 (40%) concerned the wrong route of administration, 12
(23%) subcutaneous insulin and 7 (13%) unfractionated heparin.
Barriers to implementation included time constraints,
inadequate staff and resources, excessive paperwork and
competing priorities. A minority of respondents indicated some
alerts were not relevant to small rural services. Suggestions for
improving the audit tools included making them less labour
intensive, enabling electronic responses and ensuring their
distribution is coordinated with other medicine-related tools.
Conclusion: High-risk medicines alerts and the accompanying
audit tools facilitated change but there were some barriers to
their implementation, such as time and resource constraints.
Not all alerts and audit tools were relevant to all health services.
J Pharm Pract Res 2010; 40: 203-6.
INTRODUCTION
Medicines are the most commonly used treatment in
health care and are associated with more adverse events
than any other treatment (33% of Australian adults take
5 or more medicines).1 An estimated 1.5 million Australians
experience a medicine-related adverse event each year
resulting in around 400 000 visits to general practitioners
and 140 000 hospital admissions, at an estimated cost of
$380 million in 2002.2,3 Medicine-related errors can occur
anywhere in the medicine management pathway.
Medicine-related adverse events are more likely to
occur in older people, those with serious illnesses who
use multiple medicines, people using high-risk medicines
and during care transition between hospital and the
community. For example, around 30% of unplanned
hospital admissions of older people are associated with
medicines.4 Adverse events can also occur due to errors
in the medicine management pathway and when changes
to medications are not recorded on discharge summaries
or communicated among relevant health professionals.5
Many medicine-related adverse events are
preventable, e.g. an estimated 1.5 million preventable
medicine-related adverse events occur each year in the
USA.1,5,6 Greener7 developed an hypothesis-generating
heuristic estimate that suggested 59% of the 392 000
acute medicine-related hospital admissions in the UK
were avoidable. Some strategies for reducing medicine-
related adverse events include standardising medicine
management processes, improving interdisciplinary
communication, health professional and patient
education and effective use of technology.6 The
development and distribution of high-risk medicines
alerts and bulletins in the US and the UK resulted in
national and international systems changes.3,8,9 Change
is critical to the success of such strategies and according
to Kotter10 the key elements of effective change are:
• establishing a sense of urgency among staff
responsible for delivering clinical care;
• establishing and supporting key stakeholder (or
change champions) to implement change strategies;
• communicating key aspects of the strategy to all
stakeholders;
• planning for and creating conditions to achieve
short-term successes; and
• consolidating success to encourage ongoing
monitoring and improvement.
In July 2006, the interdisciplinary High Risk
Medicines Working Party, Quality Use of Medicines
Program, Department of Health (Victoria) was established
to develop strategies to minimise risks associated with
the high-risk medicines described within the acronym:
PINCH – potassium, insulin, narcotics, chemotherapy
and heparin, as well as address systems for managing
high-risk medicines. During 2008 and 2009, three high-
risk medicines alerts (wrong route of administration of
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oral medicines, subcutaneous insulin, unfractionated
heparin) were developed and distributed to 90 Victorian
health services.11 They were primarily developed to inform
health services about adverse events concerning these
medicines and associated administration systems, and
factors that contributed to the adverse events and
strategies to prevent future adverse events. The
accompanying audit tools were simultaneously
developed and distributed to assist health services
perform a gap analysis of processes around high-risk
medicines usage in relation to the recommendations within
the alert.
There are limited data on the impact of high-risk
medicines alerts on health services’ medicine
management systems and the utility of the audit tools in
clinical practice. This study aimed to determine the impact
of the three high-risk medicines alerts on Victorian health
services; to assess the clinical relevance and utility of
the audit tools; to identify barriers to implementing
recommendations; and to obtain feedback and
suggestions for future alert topics.
METHOD
From February 2008 to March 2009, the three high-risk
medicines alerts and accompanying audit tools were
distributed to the 90 chief executive officers of Victorian
metropolitan, regional and rural public health services
with a letter requesting they distribute them to the clinical
governance, quality use of medicines, drug and
therapeutics, and medication safety committees, as well
as directors of medical, pharmacy and nursing services.
The decision to implement the recommendations in the
alerts and audit tools was devolved to the health services,
rather than mandated by the Department of Health.
The alerts and audit tools were also posted on the
High Risk Medicines’ web site at the time they were
distributed to the chief executive officers. They were also
distributed via e-mail to stakeholders such as the directors
and deputy directors of pharmacy, quality managers and
the Victorian Quality Use of Medicines Network.
The alerts and accompanying audit tools were
circulated at the following times: wrong route of
administration in February 2008; subcutaneous insulin
in December 2008; and unfractionated heparin in March
2009. Health services were expected to implement the
alerts to comply with Victoria’s clinical governance
framework, which expects known clinical risks to be
addressed proactively.12 The audits could be completed
before, during or after the implementation of the
recommendations as they provided a gap analysis of
processes that needed to be addressed.
A cross-sectional survey was undertaken from 6 to
31 July 2009 using an online questionnaire developed for
the study. The questionnaire consisted of 12 questions:
mixture of five-point Likert scales and open-ended and
closed questions. Face and content validity of the
questionnaire were established with a panel of experts
(pharmacists, nurses, a general practitioner, a physician)
prior to dissemination.
Participants were informed about how the data would
be used and that completing and returning the
questionnaire would be taken as consent to use the data.
Data were analysed using descriptive statistics
including frequencies and percentages. Content analysis
of the open-ended questions was undertaken using the
five-step framework method: becoming familiar with the
data, identifying a thematic framework, indexing and
charting key themes, and mapping and interpreting the
findings.13 Two of the authors independently undertook
analysis in NVivo (version 1.2.142) and then discussed
the findings until they reached consensus.
RESULTS
Most of the 90 respondents were pharmacists (53%) and
nurses (31%), and the remaining 16% were administrators
or ‘other’. Most respondents were also involved in
implementing the alerts and undertaking the audits in
their health services. The number of responses was fairly
evenly distributed among the three alerts (Table 1). As
the responses were anonymous it was not possible to
determine their origin or whether multiple responses were
returned from the same organisation.
Influence on Practice
The majority of respondents (86%) noted that the alerts
helped identify areas that needed improvement in their
organisations and 90% noted that the alerts improved
patient safety. Fifty-nine per cent of respondents made
changes to existing practices and/or policies as a result
of receiving the alerts. Of these, 40% concerned the wrong
route of administration, 23% subcutaneous insulin and
13% unfractionated heparin alerts (Table 2).
Responses to the open-ended questions suggested
that the alerts and audit tools acted as catalysts for change
by bringing the high-risk medicines to the attention of
health professionals. They enhanced interdisciplinary
discussion and resulted in review of and changes to
practices and policies. One respondent stated: ‘The audit
was a very valuable tool and it made the process of
‘change’ in our hospital so much easier’.
Respondents noted that planned, targeted staff
education, completing audits and improving staff
medication knowledge and competence were necessary
to the change process. As a result of the alerts, some
hospitals included medicines alerts and high-risk
medicines information in orientation packs for new staff.
Some respondents noted that their hospitals were
preparing to make changes in response to locally
identified needs regarding high-risk medicines before
they received the alerts and audit tools. They reported
that the alerts supported the need for change in their
hospitals. While others reported that the alerts were
important education tools. For example, one respondent
indicated that their hospital was not aware dispensers
for administering oral medicines were available before
they received the wrong route of administration alert.
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Barriers to Implementing the Alerts
Forty-two respondents did not answer the question
about barriers to implementing the alerts. Of the 48 people
that responded, 48% indicated there were no barriers
and 52% cited a number of barriers (Table 3). Some
respondents reported a lot of time-consuming preliminary
work was needed to implement an alert and audit plan
such as preparing education material and disseminating
messages to all clinical staff.
professionals. Respondents who provided feedback
about ‘barriers’ suggested ‘management direction and
support’ was essential to successful implementation.
Some respondents commented that general practitioners
were reluctant to adhere to the recommendations, for
example not following the directive to write ‘units’ when
prescribing insulin doses and using ‘IU’.
While the audit tool was considered to be ‘great for
large health services’ there was a suggestion that they
could be tailored to suit small rural health services.
Improving Alerts and Future Topics
A number of suggestions for improving the alerts and
audit tools were received, which will be considered when
developing future topics for the high-risk medicines alerts
program (Table 4). The majority (79%) of respondents
noted it would be useful if the completed audits could be
submitted electronically to a central database for
benchmarking purposes. Topics suggested for future
alerts included: insulin infusions; cytotoxics; opioids;
pumps; processes for recording allergies; clinical
handover; labelling and packaging; omission of
medicines; and neonatal nasogastric feeds.
DISCUSSION
Although the overall response rate could not be
determined, the range and content provided valuable
qualitative information on the impact, implementation and
future recommendations for alert development.
Implementing the three alerts and undertaking the audits
were in various stages of completion in most health
services at the time of the survey, which could have
impacted on the type and amount of information
provided, and the number of responses received.
Most of the respondents were pharmacists and
nurses, possibly because they undertake the bulk of the
medicine-related activities (excluding prescribing) in
hospitals. The responses suggest pharmacists and nurses
are noticeably active in managing system change to
improve safe and effective use of high-risk medicines.
Successful implementation of the recommendations
in the alerts and completing the audits required
interdisciplinary support and collaboration. Some
respondents described difficulties when establishing the
audit process, which was interpreted as ‘telling people
how to do their work’, which the respondents noted
reflected the ‘power relationships’ among health
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Respondents noted that the alerts and audit tools
acted as catalysts for change in their hospitals. The alerts
appeared to have stimulated health services to assess
their performance and share information to make it easier
for others to learn from their successes and failures and
help foster a culture of safety. Self-assessment, sharing
information and fostering a culture of safety are key
recommendations of the Institute of Medicine.6
Interestingly, Kotter’s key elements of change, i.e.
creating a sense of urgency, support, communication and
planning, were consistent with the change management
strategies highlighted by respondents to be important
contributors to effective implementation of the alerts.10
Significantly, changes were made to policies as a result
of the three alerts, for example insulin charts, product
rationalisation and availability of dispensers for
administering oral liquid medicines via gastrostomy tubes.
However, the factors that drove the change were not
explored in this study. The role of the alerts as change
agents requires further investigation.
Some respondents reported insulin doses were still
being written as ‘IU’ instead of ‘units’. Although the
magnitude of the problem is unknown, it is of concern,
given the large amount of education on this topic that
has been targeted to health professionals. Additionally,
the two case studies on the subcutaneous insulin alert
highlighted serious adverse events associated with
writing insulin doses as ‘IU’.
Competing priorities and timeframes of the alert
dissemination (three in 12 months) were reported to be
barriers to implementation. These alerts were distributed
over a year after the implementation of the National
Inpatient Medication Chart and national compulsory
alerts for potassium and vincristine. These prior
experiences were useful to inform the future national
approach to alert development.
Small rural health services reported that some alerts
were not relevant to them because of the low usage of
the drug concerned. However, infrequent use of high-
risk medicines in these health services may increase risks
and necessitate vigilance and adherence to the alert
recommendations.
Respondents cited a number of other perceived
barriers that are similar to those encountered in other
aspects of health care.1 Most concerned time and resource
constraints and local issues such as storage space.
Seventy-one per cent of respondents indicated that
the content of the alerts were relevant to their health
service. In addition, topics for future alerts were also
suggested, which included other high-risk medicines,
delivery systems and documentation. Constructive
feedback for improving the alerts and audit tools to
increase their utility will inform future delivery of the high-
risk medicines alert program and other medicine-related
communication. The findings highlight the need for
targeted staff education to improve medicine safety when
the alert recommendations are being implemented.
The limitations of qualitative self-report studies and
the small sample size need to be considered when
interpreting the results and their implications for practice.
The survey was conducted four months after the third
alert was disseminated and may not have allowed
sufficient time for the recommendations to be fully
considered and implemented.
In conclusion, high-risk medicines alerts and the
accompanying audit tools facilitated change but their
were some barriers to their implementation, such as time
and resource constraints. Not all alerts and audit tools
were relevant to all health services.
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